"100,000-won Samsung" and "600,000-won Hynix" Break Down... Impact from U.S. Tech Stock Plunge

The share prices of Samsung Electronics and SK Hynix showed weakness in the early session on November 14. This is attributed to the sharp decline in technology stocks on the New York Stock Exchange overnight, driven by renewed concerns over an artificial intelligence (AI) bubble. As of 9:25 a.m. on this day, Samsung Electronics was trading at 99,400 won, down 3.31% from the previous session, breaking below the so-called “100,000-won mark.” SK Hynix saw an even steeper drop of over 5%, trading at 581,000 won, down 5.07%. Both stocks had already fallen below the 100,000-won and 600,000-won levels, respectively, during pre-market trading. Overnight, all three major U.S. stock indices closed lower, despite the end of the U.S. federal government shutdown. This decline was attributed to subsequent uncertainty in economic indicators and hawkish comments from key Federal Reserve officials. In particular, the tech-heavy Nasdaq index fell 2.29% from the previous session, and this impact is being

Notable Stocks

11.14 09:36

Seers Technology Surges on Strong Q3 Earnings

As of 9:20 a.m. on November 14, shares of Seers Technology on the KOSDAQ market were trading at 120,000 won, up 20% from the previous day's closing price. The stock has been hitting record highs for several consecutive days, and this surge appears to be driven by the company's strong third-quarter results announced on the same day, which increase the likelihood that it will become the first domestic company in the medical AI sector to achieve an annual profit. On this day, Seers Technology disclosed through its quarterly report that it posted third-quarter revenue of 15.7 billion won and operating profit of 6.8 billion won. Compared to the same period last year, revenue jumped by 1,500% (from 980 million won), and operating profit turned positive from a loss of 3.5 billion won. Even compared to the second quarter of this year, when the company first recorded a quarterly profit, revenue and operating profit increased by 98% and 357%, respectively. As a result, Seers Technology has achie

Notable Stocks

11.14 09:25

Senatechnology Surges Over 160% on First Day of KOSDAQ Listing

Senatechnology is experiencing a surge of over 160% on its first day of trading on KOSDAQ. As of 9:11 a.m. on November 14, Senatechnology was trading at 150,700 won, up 93,900 won (165.32%) from its initial public offering price of 56,800 won. Senatechnology finalized its IPO price at the top end of its target range, 56,800 won, after recording a competition rate of 976.9 to 1 in the institutional investor demand forecast conducted from October 23 to 29. In the general subscription held on November 4 and 5, the competition rate was 885 to 1. The subscription deposit amounted to approximately 3.5 trillion won. Founded in 1998, Senatechnology is the global leader in the motorcycle team communication market. It has been selected as the Best Brand in the communication systems category for seven consecutive years by Motorrad, a German motorcycle magazine with a 120-year history.

Notable Stocks

11.14 09:18

Lunit Drops on Concerns Over Widening Losses

As of exactly 2:00 p.m. on November 13, 2025, shares of the AI bio company Lunit were trading at 39,425 won on the KOSDAQ market, down 16.65% from the previous day's closing price. This appears to be due to concerns that the timeline for turning a profit will be delayed as the company's losses have continued to grow year after year. Lunit generates revenue through its flagship AI cancer diagnosis platform "Lunit Insight," its AI cancer treatment biomarker platform "Lunit Scope," and its wholly owned subsidiary "Volpara." According to the consolidated financial statements, Lunit's revenue (operating income) was 25.1 billion won in 2023, 54.2 billion won in 2024, and 56.7 billion won as of the end of the third quarter this year. However, operating losses also increased, reaching 42.2 billion won in 2023 and 67.9 billion won in 2024. By the end of the third quarter this year, the operating loss stood at 63.5 billion won, with annual losses expected to approach 80 billion won. Previously,

Notable Stocks

11.13 14:01

Rokit Healthcare Soars on News of AI Cardiac Regeneration Patch Development...Hits Record High

Rokit Healthcare is soaring by over 24% following news that it has completed the development of an artificial intelligence (AI) cardiac regeneration patch. As of 11:12 a.m. on November 13, Rokit Healthcare is trading at 44,250 won, up 8,700 won (24.47%) from the previous day. During the session, the price climbed to 45,750 won, marking the highest level since its listing on May 12. On this day, Rokit Healthcare announced that it has completed the production of its proprietary AI cardiac regeneration patch, which replicates myocardial contraction and relaxation functions. The company plans to begin full-scale domestic and international preclinical trials using animal models of myocardial infarction.

Notable Stocks

11.13 11:17

TLB Rises Over 4% on Strong Q3 Earnings

The stock price of TLB is gaining momentum after the company announced third-quarter results that exceeded expectations this year. As of 10:16 a.m. on November 13, TLB was trading at 71,700 won, up 2,800 won (4.06%) from the previous trading day. In the third quarter, TLB posted sales of 68.9 billion won and operating profit of 8.7 billion won, up 48.5% and 111.2%, respectively, compared to the same period last year. This marks the highest sales since the company's founding, reflecting the current boom driven by the memory cycle. Operating profit was also partially boosted by one-off personnel expenses in the third quarter. On this day, Shinhan Investment Corp. maintained its "Buy" rating on TLB, stating that it is time to focus on the acceleration of earnings growth next year, and raised its target price by 11% to 90,000 won. Seo Jibeom, a researcher at Shinhan Investment Corp., said, "The expansion of high value-added substrate sales drove the overall performance. The increase in ord

Notable Stocks

11.13 10:24

Curiosis Hits Upper Price Limit on First Trading Day... Quadruples IPO Price

Curiosis surged to the upper price limit immediately upon opening on its first day of trading on the KOSDAQ. As of 10:10 a.m. on November 13, Curiosis shares were trading at 88,000 won, up 300.0%, the maximum daily increase, compared to the initial public offering price. This is four times higher than the IPO price of 22,000 won. Curiosis is a company specializing in laboratory automation equipment. Based on its proprietary "CurioSystem" platform, which incorporates core source technologies essential for laboratory automation systems, the company has launched products such as the automated cell imaging system Celloger and Cellfury. Curiosis has built a product portfolio that can be immediately supplied to large and high-growth markets, including synthetic biology, digital pathology, cell separation, live cell imaging, and automation for cell therapy applications. During the public subscription held for institutional and retail investors on November 4 and 5, Curiosis recorded a subscrip

Notable Stocks

11.13 10:24

HYBE Rises Over 3% as All NewJeans Members Announce Return

HYBE has shown strong performance for two consecutive days. This comes as all members of the girl group NewJeans, which had been in an exclusive contract dispute with its sub-label ADOR, have expressed their intention to return to the agency. As of 10:18 a.m. on November 13, HYBE was trading at 300,000 won, up 9,000 won (3.09%) from the previous trading day. The previous day, NewJeans members Minji, Hanni, and Danielle announced their intention to return to ADOR, following Haerin and Hyein, who had already stated their plans to come back to the agency. The NewJeans members had demanded the reinstatement of former CEO Min Hee-jin, who was dismissed following conflicts with HYBE. When this request was not accepted, they claimed in November of last year that their contracts were terminated due to ADOR’s breach of exclusivity agreements. ADOR asserted that the contracts with NewJeans remained valid, and in December of the same year, filed a lawsuit to confirm the validity of the exclusive

Notable Stocks

11.13 10:22